Biberach, Germany

Franz Nothelfer

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Nothelfer: Innovator in Chromatographic Methods

Introduction

Franz Nothelfer is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of biochemistry, particularly in the purification of proteins. His innovative approach has led to the development of a patented method that enhances the efficiency of protein purification processes.

Latest Patents

Franz Nothelfer holds a patent for a "Chromatographic method for purifying FC-containing proteins." This invention focuses on methods of depleting impurities, specifically host cell proteins (HCP) and DNA from cell culture supernatants. The technique utilizes protein A chromatography with a novel washing buffer, which improves the overall purification process.

Career Highlights

Throughout his career, Nothelfer has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Boehringer Ingelheim International GmbH and Novo Nordisk A/S, where he has contributed to various projects aimed at advancing biopharmaceutical manufacturing.

Collaborations

Nothelfer has collaborated with esteemed colleagues, including Christian Eckermann and Dorothee Ambrosius. These partnerships have fostered innovation and have been instrumental in the development of his patented methods.

Conclusion

Franz Nothelfer's contributions to the field of protein purification through his patented methods demonstrate his commitment to advancing biotechnological processes. His work continues to influence the industry and improve the efficiency of biopharmaceutical production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…